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Abstract
Two types of Na-independent Mg2 efflux exist in erythrocytes : (1) Mg2 efflux in sucrose medium and (2) Mg2 efflux
in high Cl3 media such as KCl-, LiCl- or choline Cl-medium. The mechanism of Na-independent Mg2 efflux in choline Cl
medium was investigated in this study. Non-selective transport by the following transport mechanisms has been excluded:
K,Cl3- and Na,K,Cl3-symport, Na/H-, Na/Mg2-, Na/Ca2- and K(Na)/H antiport, Ca2-activated K
channel and Mg2 leak flux. We suggest that, in choline Cl medium, Na-independent Mg2 efflux can be performed by non-
selective transport via the choline exchanger. This was supported through inhibition of Mg2 efflux by hemicholinum-3 (HC-
3), dodecyltrimethylammonium bromide (DoTMA) and cinchona alkaloids, which are inhibitors of the choline exchanger.
Increasing concentrations of HC-3 inhibited the efflux of choline and efflux of Mg2 to the same degree. The Kd value for
inhibition of [14C]choline efflux and for inhibition of Mg2 efflux by HC-3 were the same within the experimental error.
Inhibition of choline efflux and of Mg2 efflux in choline medium occurred as follows: quinines cinchoninesHC-
3sDoTMA. Mg2 efflux was reduced to the same degree by these inhibitors as was the [14C]choline efflux. ß 2002
Elsevier Science B.V. All rights reserved.
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1. Introduction
Previously we have shown that Mg2-loaded and
non-Mg2-loaded erythrocytes incubated in sucrose
medium showed a considerable rate of Na-inde-
pendent Mg2 e¥ux [1^3]. This Na-independent
Mg2 e¥ux could be inhibited by DIDS, SITS or
by isosmotic substitution of sucrose with NaCl,
KCl, LiCl or choline Cl [1,3], indicating that extra-
cellular Cl3 was responsible for inhibition. Inhibition
through extracellular Cl3 and DIDS was abolished
by the lipid soluble cation TPP [2]. To explain the
e¡ects of DIDS, SITS and TPP, it was concluded
that in sucrose medium the Na-independent e¥ux
of Mg2 was accompanied by net e¥ux of intracel-
lular Cl3 via capnophorine (band 3 protein) for
charge compensation. Inhibition through extracellu-
lar Cl3 has been assumed to be produced by reduc-
tion of net Cl3 e¥ux due to the dissipation of the
0005-2736 / 02 / $ ^ see front matter ß 2002 Elsevier Science B.V. All rights reserved.
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intracellular^extracellular Cl3 gradient and/or mem-
brane potential [2,3].
However, when erythrocytes were suspended in
KCl- or choline Cl-medium, there was a residual
Mg2 e¥ux that was not inhibited by DIDS and
SITS [1^3]. To explain this residual second type of
Na-independent Mg2 e¥ux, non-selective trans-
port by the following mechanisms may be consid-
ered: K,Cl3 symport, Na,K,Cl3 symport, Na/
Mg2 antiport, Na/H antiport, Na/Ca2 anti-
port, Ca2-activated K channel, K(Na)/H anti-
port, Mg2 leak e¥ux and ¢nally choline/Mg2 anti-
port. In the present study we investigated whether
one of these mechanisms may mediate Mg2 e¥ux
in Na-free high Cl3 medium.
Erythrocytes are known to contain a choline ex-
changer, which, in addition to transporting choline,
is also able to transport other cations such as Cs,
Rb, K, Li, Na and is characterized by a unique
a⁄nity to Mg2 [4]. Thus, the choline exchanger of
erythrocytes is a rather unspeci¢c transporter, also
mediating the uptake of catecholamines [5]. We
therefore also investigated whether the choline ex-
changer may perform choline/Mg2 antiport.
The experiments were conducted with non Mg2-
loaded rat erythrocytes, which have been shown by
us to exhibit a signi¢cant Na-dependent and Na-
independent Mg2 e¥ux [3] so that Mg2-loading
could be avoided; this technique has been used to
obtain a measurable rate of Mg2 e¥ux in other
cell types [6].
2. Materials and methods
2.1. Materials
Nembutal (pentobarbital-sodium), 50 mg ml31,
was from Abott, North Chicago, IL, USA; amiloride
hydrochloride, bumetanide, choline chloride, clotri-
mazole, cinchonine, cinchonidine, DoTMA, furose-
mide, HC-3, quinine and quinidine were from Sigma,
Deisenhofen, Germany. Nitrendipine was from Toc-
ris, Biotrend Chemikalien, Cologne, Germany.
[methyl-14C]Choline-HCl, speci¢c activity 2.04 GBq/
mmol, was from Amersham Pharmacia Biotech, Lit-
tle Chalfont, UK. All other chemicals were pur-
chased at the highest grade of purity available from
Merck, Darmstadt, Germany. Filtered, deionized
and virtually Mg2-free water with a resistance of
15^18 M6/cm was used for solutions.
2.2. Red cell preparation and incubation
Red cells were prepared as described earlier [3].
Blood (6^8 ml) was always obtained from one anes-
thetized (50 mg kg31 Nembutal i.p.) male Wistar rat
weighing 350^450 g, whereby the abdominal vein was
catheterized with a heparinized syringe. The blood
was transferred to heparinized tubes, diluted 1:3^
1:5 with 150 mmol l31 NaCl containing 5 mmol
l31 D-glucose and 10 mmol l31 HEPES^Tris, pH
7.4 (NaCl medium). The cell suspension was centri-
fuged at 1000Ug for 10 min at 20‡C. The plasma
and bu¡y coat containing the white cells were aspi-
rated and discarded. The red cell pellets were washed
twice at 20‡C in 10 ml NaCl medium. The pellets
were resuspended and incubated with gentle shaking
as a 10% (v/v) suspension in NaCl medium or cho-
line Cl medium containing 150 mmol l31 choline Cl,
5 mmol l31 D-glucose and 10 mmol l31 HEPES^Tris,
pH 7.4.
To prevent hemolysis, the cells were handled with
utmost caution. Normally, hemolysis ranged between
0.5% and 1.5%. Where hemolysis was greater than
2%, the red cells were not used for the experiment.
While investigating the e¡ect of various substances,
paired experiments were always performed in the dif-
ferent media.
2.3. Mg2+ e¥ux
At the beginning of incubation and at various in-
tervals, 1-ml aliquots of the cell suspensions were
centrifuged at 1000Ug for 10 min. This relatively
low speed was used to minimize hemolysis. To deter-
mine Mg2, the supernatant was diluted with TCA.
The ¢nal concentration of TCA was 5% (w/v), con-
taining 0.1% (w/v) La2O3 and 0.16% (v/v) HCl. Mg2
was measured in triplicate by atomic absorption
spectrometry (Perkin Elmer, 2380). Mg2 e¥ux was
calculated from the di¡erence in the increase of
extracellular Mg2 concentration during the time in-
tervals and was related to the original cell volume
measured by hematocrit. Hematocrit and hemolysis
were measured in each sample.
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2.4. [14C]Choline £uxes
2.4.1. [14C]Choline in£ux
The unidirectional in£ux of [14C]choline was deter-
mined as described previously [7]. Brie£y, the red
cells were washed (three times) in NaCl medium.
Then, the cells were resuspended (hematocrit 10%)
in NaCl medium containing [14C]choline. Final activ-
ity was 18.5 kBq ml31 (0.5 WCi ml31) in the concen-
tration range of 5^100 Wmol l31 choline and 37 kBq
ml31 (1 WCi ml31) for the higher choline concentra-
tions up to 5 mmol l31. Furthermore, at choline Cl
concentrations greater than 50 Wmol l31, the NaCl
concentration was adequately lowered so that total
NaCl and choline Cl was 150 mmol l31.
Duplicate experiments were carried out in a ¢nal
sample volume of 1.2 ml at room temperature. After
3 h, choline in£ux was terminated by transferring
0.4-ml aliquots of the suspensions to microcentrifuge
tubes containing 0.8 ml dibutylphthalate. The cells
were sedimented beneath the oil by centrifugation
(15 000Ug for 1 min). The aqueous supernatant
was removed by aspiration and the radioactivity re-
maining on the walls was removed by washing (four
times) with water. Dibutylphthalate was aspirated.
The cell pellet was lysed for at least 15 min in 600
Wl Triton X-100 (0.1% v/v) and precipitated through
the addition of 600 Wl TCA (5% w/v %) and subse-
quent centrifugation (15 000Ug for min). The 14C-
activity of 1.1 ml of the lysate was measured in a
L-scintillation counter. The in£ux rate was expressed
in Wmol choline l cells31 h31 and corrected for extra-
cellular space in the cell pellet, the latter being esti-
mated from the amount of [14C]choline in pellet sam-
ples taken within a few seconds after addition of
[14C]choline.
In preliminary experiments (not shown) it was en-
sured that the time course of choline uptake was
linear over a period of up to 4 h. This was estab-
lished for 0.1 mmol l31 and 5 mmol l31 choline.
Therefore, the in£ux rates determined in later experi-
ments fell within the linear period.
2.4.2. [14C]Choline e¥ux
[14C]Choline e¥ux was measured after loading the
erythrocytes at room temperature with 10 mmol l31
14C-labeled choline Cl (¢nal activity 74 kBq ml31 = 2
WCi ml31) for 20^24 h. Also glucose was added, ¢nal
concentration 20 mmol l31. Next day, when a steady
state distribution of choline could be expected [4], the
loaded erythrocytes were washed (three times) at
1000Ug in 5 ml of a solution of 10 mmol l31 unla-
beled choline Cl, 140 mmol l31 NaCl and 20 mmol
l31 HEPES^Tris, pH 7.4. Finally, the red cells were
suspended (hematocrit 10% v/v) in choline Cl me-
dium. After 2 h, e¥ux was terminated by transfer-
ring 0.5-ml aliquots to microcentrifuge tubes contain-
ing 700 Wl dibutylphthalate and centrifuging at
15 000Ug for 1 min. The subsequent procedure was
the same as that described for [14C]choline in£ux.
2.5. Statistical analysis
Data were expressed as mean values þ S.E.M. and
statistical di¡erences were determined by Student’s
paired and two-tailed t-test. A value of P6 0.05
was considered signi¢cant.
3. Results and discussion
3.1. Exclusion of K+,Cl3- and Na+,K+,Cl3-symport
Erythrocytes can perform K,Cl3- and Na,K,
Cl3-symport. A role played by these transporters
in Mg2 e¥ux could be excluded for the following
reasons:
K,Cl3 symport is activated by hypoosmotic
swelling and Na,K,Cl3-symport is activated by
hypertonic shrinkage [8,9]. Our experiments were
performed under isoosmotic conditions. Therefore,
these transporters would not be active.
K,Cl3- and Na,K,Cl3-symport are inhibited
by furosemide and bumetanide [8,10]. In preceding
experiments with non Mg2-loaded rat erythrocytes,
0.1 mmol l31 furosemide had no e¡ect on Mg2 ef-
£ux in NaCl and choline Cl medium [3]. In this study
(Table 1), we found that even the high concentration
of 1 mmol l31 furosemide did not a¡ect Mg2 e¥ux
in choline Cl medium. Moreover, 0.01 mmol l31 and
0.1 mmol l31 bumetanide, which is a more potent
inhibitor of K,Cl3- and Na,K,Cl3-symport
[8,10], also had no e¡ect on Mg2 e¥ux in choline
medium (Table 1).
K,Cl3- and Na,K,Cl3-symport are speci¢cally
dependent on Cl3 [8]. After substituting Cl3 with
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NO33 , SCN
3, Mg2 e¥ux was not abolished (not
shown).
In agreement with the Cl3 independence of Na-
independent Mg2 e¥ux in high Cl3 medium, 0.1
mmol l31 ni£umic acid (an inhibitor of Ca2-acti-
vated Cl3 channel [11] and of Cl3 transport through
band 3 protein [12]) did not a¡ect Mg2 e¥ux in
choline Cl medium (Table 1).
3.2. Exclusion of Na+/H+ antiport
Next, we considered whether Mg2 e¥ux in cho-
line Cl3 medium might operate via non-selective
transport by the Na/H antiporter. Na/H anti-
port is inhibited by amiloride [13]. In non-Mg2-
loaded rat erythrocytes, 0.5 mmol l31 amiloride in-
hibited Mg2 e¥ux in NaCl medium by 25% and in
choline medium by 62% ([3] and Table 1). Since in-
hibition of Na/H antiport occurs at 10 times lower
amiloride concentrations, which do not e¡ect Mg2
e¥ux [14], Na/H antiport cannot be involved in
Mg2 e¥ux. Moreover, at physiological intracellular
pH, Na/H antiport is practically quiescent and is
activated by intracellular acidi¢cation due to the
binding of H to a modi¢er site [15]. Finally, it
was reported that Na+/H+ antiport is absent in rat
erythrocytes [16].
3.3. Exclusion of Na+/Mg2+ antiport
Na/Mg2 antiport is inhibited by amiloride and
quinidine [3,17]. As mentioned in Section 3.2, in non-
Mg2-loaded rat erythrocytes, amiloride inhibited
Mg2 e¥ux in NaCl medium and in choline Cl me-
dium ([3] and Table 1). In addition, we found that
the cinchona alkaloids quinine and quinidine inhib-
ited Mg2 e¥ux both in NaCl medium and in cho-
line Cl medium (Table 2). From these results it can-
not be excluded that Na-independent Mg2 e¥ux
may operate via Na/Mg2 antiport. However, in
preceding experiments we found that Na/Mg2
antiport is speci¢c for Na, not operating for exam-
ple with K or Li instead of Na [18,19]. As also
shown in Table 2, at 1.2 mmol l31 other cinchona
alkaloids such as cinchonine and cinchonidine inhib-
ited Mg2 e¥ux only in choline Cl medium but not
in NaCl medium. Taken together, both ¢ndings are
strong arguments that Mg2 e¥ux in choline Cl me-
dium is not performed by non-selective transport via
Na/Mg2 antiport.
3.4. Exclusion of Na+/Ca2+ antiport
In both this study (Table 1) as well as a previous
one [3] we demonstrated inhibition of Mg2 e¥ux in
choline medium by amiloride. At the same concen-
tration, amiloride can inhibit Na/Ca2 antiport [14].
This may indicate Mg2 e¥ux by Na/Ca2 antiport.
However, it was found that Na/Ca2 antiport was
competitively inhibited by Mg2 that was not trans-
ported by the Na/Ca2 antiporter [20]. This ¢nding
is in contrast to a recent study showing that the iso-
forms NCX1 and NCX3 of the Na/Ca2 antiporter
may perform Mg2 in£ux [21].
In experiments with Mg2-loaded chicken and hu-
man erythrocytes, additional loading with Ca2 did
not inhibit Mg2 e¥ux via Na/Mg2 antiport
[18,22], indicating that Ca2 did not interfere with
the Na/Mg2 antiporter in these types of erythro-
cytes.
Table 1
E¡ect of various ion transport inhibitors on Mg2 e¥ux of rat erythrocytes
Inhibitor Concentration (mmol l31) Mg2 e¥ux (Wmol l cells31 2 h31) % of control
Control 143.3 þ 8.7 100
Amiloride 0.5 54.5 þ 3.9* 38
Furosemide 1.0 149.3 þ 23.2 104
Bumetanide 0.01 153.6 þ 7.3 107
Bumetanide 0.1 140.3 þ 7.4 98
Ni£umic acid 0.1 151.6 þ 10.3 106
Nitrendipine 0.01 157.8 þ 8.6 110
Clotrimazole 0.01 170.7 þ 12.9 119
A 10% (v/v) cell suspension was incubated in choline Cl3 medium for 2 h. Means þ S.E.M., n = 4^6. *P6 0.05.
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To date, Na/Ca2 antiport in erythrocytes has
only been described in dog and ferret. In all other
erythrocytes, Na/Ca2 antiport appears to be ab-
sent [23^26]. Thus, in rat erythrocytes the exchange
of intracellular Mg2 for extracellular Ca2 or Na
by Na/Ca2 antiport cannot be expected. More-
over, our experiments were performed in nominally
Na- and Ca2-free medium. Also, Na/Ca2 anti-
port is Na-speci¢c and not active with Li,K and
choline [20]. Therefore, Na/Ca2 antiporter could
not operate as an Mg2 transporter in rat erythro-
cytes under our experimental conditions.
3.5. Exclusion of Ca2+-activated K+ channel
Another candidate for Mg2 transport might be
the Ca2-activated K channel (Gardos channel).
We tested the e¡ect of 10 Wmol l31 nitrendipine
and clotrimazole, which are inhibitors of the Ca2-
activated K channel [27^29]. Both substances were
without e¡ect on Mg2 e¥ux in choline Cl medium
(Table 1). We therefore exclude the Ca2-activated
K channel as a Mg2 transport mechanism. This
assumption is supported by the fact that this channel
is only operating when the intracellular Ca2 concen-
tration is elevated, which was not the case under our
conditions.
3.6. Exclusion of K+(Na+)/H+ exchanger
Finally it should be noted that a K(Na)/H ex-
changer as discussed by Kummerow et al. [30] may
also be excluded, since this exchanger is only operat-
ing in erythrocytes incubated in low-ionic-strength
medium, e.g., sucrose medium.
3.7. Exclusion of Mg2+ leak £ux
As shown below (Tables 2 and 3, Figs. 1^3), leak
e¥ux as the main mechanism for Na-independent
Mg2 e¥ux in high Cl3 medium can also be ex-
cluded, since Mg2 e¥ux in choline Cl3 medium
could be inhibited by various inhibitors such as
HC-3, DoTMA and some cinchona alkaloids. Since
Mg e¥ux was not completely abolished by these
inhibitors under the conditions used, some residual
Mg2 leak e¥ux may be possible (see below, Section
3.8.4).
3.8. Choline/Mg2+ antiport
3.8.1. E¡ect of choline transport inhibitors on Mg2+
e¥ux
Since amiloride and quinidine are not speci¢c in-
hibitors of Na/Mg2 antiport, and since the Na-
independent Mg2 e¥ux occurred in choline Cl me-
dium, we investigated whether the choline antiporter
can mediate Mg2 e¥ux.
Erythrocytes (and other cell types) possess (a)
transport system(s) for choline. Human erythrocytes
have been shown to exhibit a high-a⁄nity, low-ca-
pacity choline transporter, which can exchange intra-
cellular or extracellular choline for Cs, Rb, K,
Li, Na [4] and a low-a⁄nity, high-capacity choline
transporter, which is induced by malaria infection
[7,31]. To our knowledge, choline transport in rat
erythrocytes has not as yet been investigated. We
therefore investigated whether these cells also express
a choline exchanger.
First, the e¡ect of choline transport inhibitors on
Mg2 e¥ux was tested. Fig. 1, which is analogous in
form with the Lineweaver^Burk curve, shows the
dose-dependent inhibition of Mg2 e¥ux in choline
Cl medium by HC-3, which is a speci¢c competitive
inhibitor of choline transport [32]. Calculation of the
Kd value (according to [33]) delivered a value of
4.6 þ 0.4 mmol l31 (mean þ S.E.M., n = 5).
Another inhibitor of choline transport in erythro-
cytes of di¡erent species is DoTMA [32,34]. In anal-
ogy to Fig. 1, again a dose-dependent inhibition of
Mg2 e¥ux in choline Cl medium could be pro-
duced. The Kd value of DoTMA was 0.19 þ 0.03
mmol l31 (mean þ S.E.M., n = 6). At concentrations
equal to or greater than 0.5 mmol l31 DoTMA, he-
molysis was larger than 5% so that the dose^e¡ect
relationship could be only investigated up to 0.35
mmol l31 of DoTMA. In rat erythrocytes, DoTMA
was a much less potent inhibitor of Mg2 e¥ux than
HC-3. The weaker e¡ect of DoTMA in comparison
with HC-3 has also been found for choline transport
in erythrocytes of other species [32,34].
Several cinchona alkaloids have been described as
other potent inhibitors of choline transport in human
erythrocyte [31]. We therefore tested the e¡ect of
cinchonine on Mg2 e¥ux. Cinchonine also pro-
duced a dose-dependent inhibition of Mg2 e¥ux
in choline Cl medium. The Kd value for inhibition
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of Mg2 e¥ux in choline Cl medium has been calcu-
lated to be 1.28 þ 0.07 mmol l31 (mean þ S.E.M.,
n = 4). It should be mentioned that quinine, quinidine
and cinchonidine also proved to be e¡ective inhibi-
tors of Mg2 e¥ux in choline Cl medium (Table 2).
To provide evidence for the speci¢city of the in-
hibitory e¡ects of HC-3, DoTMA and cinchonine on
Mg2 e¥ux in choline Cl medium, the e¡ect of these
inhibitors at the concentration of the Kd values has
also been measured in NaCl medium. Table 2 shows
that HC-3 and DoTMA did not inhibit but rather
stimulated Mg2 e¥ux in NaCl medium. Quinine
and quinidine inhibited Mg2 e¥ux both in choline
Cl and NaCl medium. Most interestingly, at a con-
centration of 1.2 mmol l31 the related drugs cincho-
nine and cinchonidine inhibited Mg2 e¥ux in cho-
line Cl medium by approximately 50% but had no
e¡ect in NaCl medium. Higher doses of cinchonine
stimulated Mg2 e¥ux in NaCl medium but inhib-
ited Mg2 e¥ux in choline Cl medium to a higher
degree (data not shown).
Since the choline transporter also has an a⁄nity to
K [4], the Kd values for the inhibition of Mg2
e¥ux by the choline transport inhibitors have been
determined in KCl medium. We found that the Kd
values for HC-3, DoTMA and cinchonine were al-
most the same as in choline Cl medium (n = 4, results
not shown). This ¢ts well with the properties of the
choline transporter and lends further support for a
function of the choline transporter in Na-independ-
ent Mg2 e¥ux.
Through the help of inhibitors we have thus shown
that cinchonine and cinchonidine, which are inhibi-
tors of choline transport inhibit Mg2 e¥ux only in
choline Cl medium but not in NaCl medium. This
¢nding gives support to a Mg2/choline antiport
mechanism and encouraged us to more directly in-
vestigate choline £uxes in rat erythrocytes for com-
parison and correlation with Mg2 £uxes under the
same conditions.
3.8.2. [14C]Choline e¥ux
To measure choline e¥ux, rat erythrocytes were
loaded overnight with 10 mmol l31 choline Cl labeled
with [14C]choline. Under these conditions, the intra-
cellular choline concentration was 293 þ 21 Wmol l
cells31 (mean þ S.E.M., n = 4). This concentration is
well above the physiological intracellular choline
concentration, which in human erythrocytes lies
within the range of 18^21 Wmol l cells31 [35].
Fig. 2 shows the time course of [14C]choline e¥ux,
Fig. 1. Double reciprocal plot of the inhibition of Mg2 e¥ux
of rat erythrocytes in choline Cl medium at various concentra-
tions of HC-3. The regression line was calculated using the
least-square method. The Kd value was calculated according to
[33]. Mean values of ¢ve experiments.
Table 2
E¡ect of various choline transport inhibitors on Mg2 e¥ux of rat erythrocytes
Mg2 e¥ux (Wmol l cells31 2 h31)
Substance Inhibitor (mmol l31) NaCl medium % of control Choline Cl medium % of control
Control 223.9 þ 7.9 100 140.3 þ 6.3 100
HC-3 4.6 282.4 þ 7.0* 126 95.7 þ 8.2* 68
DoTMA 0.2 247.7 þ 8.3* 111 128.5 þ 3.7* 92
Quinine 1.2 169.5 þ 6.7* 76 53.8 þ 3.6* 38
Quinidine 1.2 101.3 þ 5.5* 45 32.6 þ 1.1* 23
Cinchonine 1.2 221.0 þ 14.0 99 75.1 þ 12.4* 54
Cinchonidine 1.2 209.2 þ 8.9 93 74.1 þ 6.0* 53
A 10% (v/v) cell suspension was incubated in (a) NaCl medium or (b) choline Cl medium for 2 h. Means þ S.E.M., n = 4^6. *P6 0.05.
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which was slightly more curvilinear over 2 h than it
was in the investigations by others in human eryth-
rocytes [4]. To compare [14C]choline e¥ux with
Mg2 e¥ux, [14C]choline e¥ux was measured over
2 h, which is the same time used to determine
Mg2 e¥ux. [14C]Choline e¥ux ranged from 103 to
147 Wmol l cells31 2 h31 (Fig. 2 and Tables 1^3). This
was identical to the magnitude of Mg2 e¥ux in
choline Cl medium, which at 2 h ranged from 110
to 140 Wmol l cells31 2 h31 (Tables 1^3). Thus the
capacity of the choline exchanger would be su⁄cient
to mediate Mg2 e¥ux in choline Cl medium.
Next, the e¡ect of some choline transport inhibi-
tors on [14C]choline e¥ux was investigated. To better
compare the e¡ect of these drugs on [14C]choline
e¥ux with their e¡ect on Mg2 e¥ux of rat eryth-
rocytes in choline Cl medium, the substances were
tested at their Kd concentration for Mg2 e¥ux in
choline Cl medium. The results are shown in Table 3.
It can be seen that the inhibitors reduced choline
e¥ux as follows: quinines cinchoninesHC-
3sDoTMA. This is the same series that was ob-
tained for the inhibition of Mg2 e¥ux in choline
medium (Table 2).
To compare the magnitude of the inhibition of
[14C]choline e¥ux by HC-3 with the magnitude of
inhibition of Mg2 e¥ux by HC-3, the Kd value
for the inhibition of [14C]choline e¥ux by HC-3
was also evaluated. As can be derived from Fig. 3,
a Kd value of 5.9 þ 0.9 mmol l31 was obtained.
3.8.3. [14C]Choline in£ux
To obtain more clarity on the role of the choline
transporter in Mg2 e¥ux, we investigated
[14C]choline in£ux. NaCl medium was used for the
following reasons: (1) for comparison with choline
in£ux measured by other authors in human erythro-
cytes and (2) because measurement of choline in£ux
in choline medium would need too high a [14C]-ac-
tivity. No attempts have been made to completely
deprive the red cells of choline to really reach true
zero trans conditions for choline. In pilot experi-
ments we found a complete linear time dependence
of [14C]choline in£ux over 4 h at the two concentra-
tions of 100 Wmol l31 and 1 mmol l31 of choline
(n = 2, not shown). As demonstrated later, the used
concentration of 100 Wmol l31 external choline is
near to the Km value of choline in£ux. The physio-
logical serum concentrations were reported to be in
the range of 10^20 Wmol l31 in man, dog and rabbit
[36,37].
The linearity with time allowed us to determine the
apparent Km value for [14C]choline in£ux. Fig. 4A
shows a typical Michaelis^Menten kinetic with in-
creasing [14C]choline in£ux at increasing extracellular
choline concentration, approaching saturation at val-
ues above 5 mmol l31 choline Cl. The Hofstee plot
(see Fig. 4B) showed that there was only a single
saturable choline transporter (between 5 Wmol l31
and 5 mmol l31 of choline Cl). Calculation of the
apparent Km yielded 59.3 Wmol l31 (between 5 and
Fig. 3. Double reciprocal plot of the inhibition of [14C]choline
e¥ux of rat erythrocytes in choline Cl medium at various con-
centrations of HC-3. The regression line was calculated using
the least-square method. The Kd value was calculated according
to [33]. Mean values of ¢ve experiments.
Fig. 2. Time course of the [14C]choline e¥ux of rat erythrocytes
loaded with [14C]choline for 20 h. E¥ux was measured in cho-
line Cl medium. Means þ S.E.M., n = 3.
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250 Wmol l31 choline Cl), indicating the existence of
only one type of choline exchanger in rat erythro-
cytes as in non-malaria-infected human erythrocytes
[38]. Our Km value for choline in£ux in rat erythro-
cytes is similar to that found in eel erythrocytes for
isoosmotic choline transport [34] but somewhat high-
er than in human erythrocytes where 25^56 Wmol l31
have been found, dependent on the used medium [4].
3.8.4. Relationship between [14C]choline e¥ux and
Mg2+ e¥ux
To estimate the relationship between [14C]choline
e¥ux and Mg2 e¥ux we compared the e¡ect of
di¡erent doses of HC-3 on Mg2 e¥ux and
[14C]choline e¥ux. As is shown in Fig. 5, the e¥ux
rate of Mg2 and choline was linearly correlated.
This shows that the e¥ux of Mg2 and choline are
identically inhibited by HC-3. This could mean that
one choline or one Mg2 are transported by the same
mechanism. In agreement with the identical inhibi-
tion of [14C]choline e¥ux and Mg2 e¥ux by HC-3,
the Kd values of HC-3 for inhibition of [14C]choline
e¥ux (5.9 mmol l 31, see Section 3.8.2) and of Mg2
e¥ux (4.6 mmol l31, see Section 3.8.1) were, within
the experimental error, the same. Moreover, when
the inhibition of choline e¥ux in choline medium
Fig. 4. (A) Kinetic of [14C]choline in£ux in rat erythrocytes in-
cubated in NaCl medium. Michaelis^Menten plot of
[14C]choline in£ux with increasing choline concentrations.
Means þ S.E.M., n = 4^6. (B) Hofstee plot of values from A.
The regression line was calculated using the least-square meth-
od. Mean values, n = 4^6.
Fig. 5. Correlation of [14C]choline e¥ux with Mg2 e¥ux from
rat erythrocytes inhibited by various concentrations of HC-3 (0,
1, 2.5, 5 and 10 mmol l31). The regression line was calculated
using the least-square method. Means þ S.E.M., n = 4^5.
Table 3
E¡ect of various choline transport inhibitors on [14C]choline e¥ux of rat erythrocytes
Inhibitor Concentration (mmol l31) [14C]Choline e¥ux (Wmol l cells31 2 h31) % of control
Control 147.8 þ 8.5 100
HC-3 4.6 68.9 þ 6.8* 47
DoTMA 0.2 105.5 þ 12.7* 71
Quinine 1.2 38.6 þ 8.5* 26
Cinchonine 1.2 50.3 þ 6.6* 34
The cells were loaded with 10 mmol l31 of [14C]-labeled choline for 20^24 h. After washing, the cells were suspended (hematocrit 10%
v/v) in choline Cl medium. E¥ux was measured for 2 h. For details see Section 2.4. Means þ S.E.M., n = 5. *P6 0.05.
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(Table 3) and the inhibition of Mg2 e¥ux by qui-
nine, cinchonine, HC-3 and DoTMA (Table 2) were
correlated, a linear relationship was obtained (Fig.
6). Again, this result may be taken as evidence that
the choline exchanger can perform Mg2 e¥ux via
choline/Mg2 exchange. However, in these experi-
ments with inhibitor concentrations at their Kd val-
ues, residual Mg2 e¥ux exceeded choline e¥ux.
This may result from some Mg2 leakage induced
by the inhibitors at the used concentrations.
3.9. Concluding remarks
All inorganic cation transporters so far known in
erythrocytes as a possible non-selective transport
mechanism for Mg2 e¥ux in choline Cl medium
were excluded. The cumulative evidence for Mg2/
choline antiport in rat erythrocytes is as follows:
The choline exchanger of erythrocytes is unspe-
ci¢c, also transporting Cs, Rb, K, Li, Na
and catecholamines [4,5].
[14C]Choline e¥ux in choline Cl medium was the
same as Mg2 e¥ux in choline Cl medium. Thus,
the capacity of the choline exchanger would be
su⁄cient to mediate Mg2 e¥ux in choline me-
dium.
HC-3, a speci¢c inhibitor of choline transport
[32], and cinchonine did not inhibit Mg2 e¥ux
in NaCl medium but only in choline Cl medium,
when used at the Kd value for Mg2 e¥ux in
choline Cl medium.
Mg2 e¥ux and [14C]choline e¥ux were inhibited
by several speci¢c (HC-3, DoTMA) and less spe-
ci¢c inhibitors (quinine, quinidine, cinchonine,
cinchonidine). The Kd values for the inhibition
of Mg2 e¥ux and of [14C]choline e¥ux by
HC-3 were the same within the experimental er-
ror.
Reduction of choline e¥ux by various inhibitors
(quinine, cinchonine, HC-3 and DoTMA) was
linearly correlated to the reduction of Mg2 e¥ux
in choline Cl medium.
These results indicate the participation of the choline
exchanger in Mg2 e¥ux. The physiological signi¢-
cance of Mg2 transport through non-selective trans-
port via the choline exchanger (e.g., by exchange of
Mg2 for choline or other monovalent cations) re-
mains to be established. Studies on Na-dependent
Mg2 e¥ux relying on the incubation in choline Cl
medium as a control should consider the interaction
of choline/Mg2 exchange.
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